Incidencia real de cáncer de próstata en las áreas sanitarias de la comunidad autónoma de Castilla y León durante el año 2014. Datos del registro CAPCYL

Virseda-Rodríguez, Álvaro Julio; Salvatierra, Cristina; García, Fernando L. de la Vega; Sanz, A.; Gutiérrez, Eduardo; Serrano, J.M.; Valverde, Sebastián; Polo, Carlos Sorroza; Amón-Sesmero, J.H.; Rodríguez, V.; Cortiñas, Ramón Acebo; Calleja, J; Adriazola, M.; Gala, L.; Bermúdez, R.; Moya, Ignacio; Szczesniewski, R.J.; Aramburu, Miguel Ángel López; Gómez-Veiga, F.

doi:10.1016/j.acuro.2017.10.002

Cited by 4 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The researchers attributed this high incidence to permissive opportunistic screening policies followed by primary care centres, involving serum PSA determinations in a population not recommended by clinical guidelines. Additionally, the study suggests that the same permissiveness extends to the departments involved in performing prostate biopsies in elderly patients, even in the absence of other poor parameters and despite a low probability of presenting a clinically significant tumour [28].…”

Section: What Is Happening In Practice?mentioning

confidence: 73%

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium

Beyer,

Leenen,

Venderbos

et al. 2024

JPM

View full text Add to dashboard Cite

With the new policy recommendation in 2022 to explore the possibilities of screening for prostate cancer by the European Commission, the landscape for prostate cancer early detection is evolving. In line with this recommendation, the PRAISE-U project aims to evaluate the early detection and diagnosis of prostate cancer through customised and risk-based screening programmes, with the goal to align protocols across European Union member states. This systematic review is part of the PRAISE-U project, with the goal to review the policy, medical guideline recommendations, and the current level of opportunistic screening presented in the scientific literature on prostate cancer early detection from 2016 to 2023 in European Union member states. An extensive literature search was performed on 1 June 2023 in a large number of databases, including Embase.com, Medline (Ovid), Web of Science Core Collection, Google Scholar, and Policy Commons. We identified 318 articles (qualitative, quantitative, and reviews), of which 41 were included in the full-text screening. Seventeen articles were ultimately identified as eligible for inclusion. The included articles revealed significant variations towards PSA-based early detection policies for prostate cancer in nine European countries. Despite official recommendations, opportunistic screening was prevalent across all nine countries regardless of recommendations for or against PSA-based early detection. This systematic review suggests that the current early detection policies are not fit for purpose. High levels of opportunistic screening and overdiagnosis persist, prompting policy recommendations for standardised guidelines, informed decision making, and increased awareness to improve efficiency and effectiveness in early detection.

show abstract

Section: What Is Happening In Practice?mentioning

confidence: 73%

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium

Beyer,

Leenen,

Venderbos

et al. 2024

JPM

View full text Add to dashboard Cite

show abstract

“… Posteriormente, Virseda-Rodriguez AJ et al 41 se plantearon conocer la incidencia real de CaP en las diferentes áreas sanitarias de la C. A. CyL. A través de un estudio multicéntrico de casos incidentes, en el que participaron 7 de las 9 áreas sanitarias y 11 hospitales de un total de 14.…”

Section:  Ferlay J Et Alunclassified

Influencia del protocolo diagnóstico y la edad en la Tasa de Incidencia de Cáncer de Próstata en Castilla y León según Registro Nacional 2010

Pérez¹

View full text Add to dashboard Cite

Mi andadura en la medicina y en el difícil camino de la investigación se remonta a la década de los noventa. Siempre tuve mucho interés en realizar dicho trabajo y pude tener la oportunidad gracias a mis dos magníficos directores de tesis.El Doctor Don José H. Amón Sesmero que me propuso el camino a seguir en el mundo de la urología desconocido por mí y, su aliento continúo para que no desfalleciera en el mismo y; el Doctor Don Manuel González Sagrado que ha estado apoyando con su continuo e incansable quehacer en la estadística. La amistad, confianza y disponibilidad de ambos tutores en todo momento ha sido vital para llevar a buen puerto esta tesis doctoral.A Doña Rosa Conde Vicente por las aportaciones esenciales y orientaciones siempre tan útiles.Por último, a mi familia y muy especialmente a José y Diego, por ceder parte del tiempo, por darme aliento para atenuar las adversidades y apoyarme para superarme cada día."L'essentiel est invisible pour les yeux. C'est le temps que tu as perdu pour ta rose que fait ta rose si importante. Les hommes ont oublié cette verité. Mais tune dois pas l'oublier. Tu deviens responsable pour toujours de ce que tu as apprivoisé. Tu es responsable de ta ro-se…"

show abstract

Influencia del protocolo diagnóstico y la edad en la tasa de incidencia de cáncer de próstata en Castilla y León según el registro nacional de 2010

Gutiérrez-Pérez

González-Sagrado

Conde-Vicente

et al. 2021

Actas Urológicas Españolas

View full text Add to dashboard Cite

Incidencia real de cáncer de próstata en las áreas sanitarias de la comunidad autónoma de Castilla y León durante el año 2014. Datos del registro CAPCYL

Cited by 4 publications

References 18 publications

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium

Influencia del protocolo diagnóstico y la edad en la Tasa de Incidencia de Cáncer de Próstata en Castilla y León según Registro Nacional 2010

Influencia del protocolo diagnóstico y la edad en la tasa de incidencia de cáncer de próstata en Castilla y León según el registro nacional de 2010

Contact Info

Product

Resources

About